ロード中...
Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data
BACKGROUND: Risk-targeted testing and treatment of latent tuberculosis infection (LTBI) is a critical component of the United States’ (US) tuberculosis (TB) elimination strategy, but relatively low treatment completion rates remain a challenge. Both treatment persistence and completion may be facili...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714216/ https://ncbi.nlm.nih.gov/pubmed/33270737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0243102 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|